Multi-Site STARgraft (10401) Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 111 participants.
Also called NCT07557862
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 111 participants
- Sponsor
- Healionics Corporation
- Registry
-
NCT07557862
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil, Colombia
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07557862. Randomized; double masking; primary purpose other. Start 2026-10 (anticipated); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Multi-Site STARgraft (10401) Trial
- Condition
- End Stage Renal Disease (ESRD)
- Intervention (Device)
- STARgraft (10401)
- Intervention (Device)
- Gore Propaten
- Lead sponsor
- Healionics Corporation
Record details
- Record id
cardio:ct-nct07557862- Content hash
5529256237d2e476b1e1429b3236ade6ce6bc771cfc2f0caac1978db0e5eae01